MiR‐130a has been shown to dampen the NF‐κB signaling pathway and its target gene VEGFA by reducing TNF‐α expression [112], contributing to accelerated invasion and migration in HCC [111]. Here, VEGFA is linked to hepatocellular carcinoma.